Here, although the use of azathioprine and cyclophosphamide was more frequent among patients with severe COVID-19, it did not reach statistical significance in the multivariable analysis, probably because of the small sample size of this group.
← all excerpts
Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry.
1
—
—